FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

Advanced BioMedical Technologies, Inc.: cashflow_investing

One fact, its scope and the complete path back to the official record.

Period: 2018-11-01 – 2019-01-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/ccc9cb02-5e87-48a3-ac90-3becea8df02c

Reported value

$-25.043k{"amount": -25043, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Entity
Advanced BioMedical Technologies, Inc.
Metric
cashflow_investing
Period
2018-11-01 – 2019-01-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001493152-19-004448 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T13:22:10.708243+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001385799/cashflow-investing/2019-01-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.